These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Directed cell migration via chemoattractants released from degradable microspheres. Zhao X; Jain S; Benjamin Larman H; Gonzalez S; Irvine DJ Biomaterials; 2005 Aug; 26(24):5048-63. PubMed ID: 15769541 [TBL] [Abstract][Full Text] [Related]
29. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells. Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445 [TBL] [Abstract][Full Text] [Related]
31. Multimodal imaging of nanovaccine carriers targeted to human dendritic cells. Cruz LJ; Tacken PJ; Bonetto F; Buschow SI; Croes HJ; Wijers M; de Vries IJ; Figdor CG Mol Pharm; 2011 Apr; 8(2):520-31. PubMed ID: 21381651 [TBL] [Abstract][Full Text] [Related]
32. Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant. Mueller M; Schlosser E; Gander B; Groettrup M Int J Cancer; 2011 Jul; 129(2):407-16. PubMed ID: 21207410 [TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611 [TBL] [Abstract][Full Text] [Related]
34. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265 [TBL] [Abstract][Full Text] [Related]
35. Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses. Diwan M; Elamanchili P; Lane H; Gainer A; Samuel J J Drug Target; 2003; 11(8-10):495-507. PubMed ID: 15203918 [TBL] [Abstract][Full Text] [Related]
36. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. Gupta RK; Chang AC; Siber GR Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260 [TBL] [Abstract][Full Text] [Related]
37. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres. Janoria KG; Mitra AK Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204 [TBL] [Abstract][Full Text] [Related]
38. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression. Radford KJ; Turtle CJ; Kassianos AJ; Hart DN J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122 [TBL] [Abstract][Full Text] [Related]
39. In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation. Peyre M; Fleck R; Hockley D; Gander B; Sesardic D Vaccine; 2004 Jun; 22(19):2430-7. PubMed ID: 15193406 [TBL] [Abstract][Full Text] [Related]
40. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice. Mata E; Carcaboso AM; Hernández RM; Igartua M; Corradin G; Pedraz JL Vaccine; 2007 Jan; 25(5):877-85. PubMed ID: 17070628 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]